New ‘Signature Indicates’ option on the Patient Medication Profile

Available on version 4564 is an additional ‘Signature indicates’ option has been added to the Patient Medication Profile sheet printout.

We previously had a statement that stated ‘Signature indicates review of medications (dose, effect, adverse effect, duplicate treatment, drug interactions, need for patient education, new/changed medications.’

At a customer request, we have added a second option, specifically for Hospice purposes that has ‘associated laboratory monitoring’ in it – so that statement reads: ‘Signature indicates review of medications (dose, effect, adverse effect, duplicate treatment, drug interactions, associated laboratory monitoring, need for patient education, new/changed medications.’

This entry was posted in All Messages, HHC 3000 Office Software, Medications. Bookmark the permalink.